HMPV is spreading in China but there's no need to worry
Respiratory illness is common in winter


Cases of the human metapneumovirus (HMPV) are on the rise in China, causing global concern. The respiratory virus is not new, but much of the public was previously unaware of its existence. Experts say the disease is likely not going to be the next pandemic and the worry is a result of heightened wariness for respiratory illness in a post-Covid world.
What is HMPV?
HMPV is a respiratory virus that regularly circulates during cold and flu season. It is spread through coughing, sneezing and coming into contact with contaminated surfaces. It presents as common cold symptoms including cough, fever, shortness of breath and congestion. While not deadly, in some instances, cases can be more severe, especially in young children and the immunocompromised. They could "develop more severe disease where the lungs are affected, with wheezing, breathlessness and symptoms of croup," said the BBC. This could require hospitalization.
While China seems to have a spike in cases, its "reported levels of respiratory infections were along usual and expected rates, said a news briefing by the World Health Organization (WHO). The rise of HMPV is likely because "China underwent one of the world's most restrictive and prolonged lockdowns in response to Covid, reducing people's exposure to other viruses such as HMPV," said The Washington Post. "That created a situation where people became more susceptible during a surge," leading to "unusual cases even in young and middle-aged adults." The surge also aligns with low temperatures expected to last until March.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Should people be worried?
Experts aren't sounding the alarm just yet about HMPV. "It's not a new virus," Margaret Harris, a spokesperson for the WHO, said in the news briefing. "It was first identified in 2001. It's been in the human population for a long time. It is a common virus that circulates in winter and spring." The disease has been circulating similar to the flu, RSV and walking pneumonia. "How many times do you get sick in the winter and you have no idea what you've got?" said Jennifer Nuzzo, a professor of epidemiology and director of the Pandemic Center at the Brown University School of Public Health, to the Post. "It's a virus you'll get. You'll probably get it multiple times in your life."
HMPV is also not expected to be a global pandemic like Covid-19. The disease is well-studied and has been known for a long time. "There is broad population-level immunity to this virus globally; there was none, for Covid," said The New York Times. "A severe HMPV season can strain hospital capacity — particularly pediatric wards — but does not overwhelm medical centers." While there is no vaccine or antiviral for the disease, in most people it tends to pass on its own.
In general, "there's just this tendency post-Covid to treat every infectious disease anything as an emergency when it's not," Amesh Adalja, an infectious diseases physician and senior scholar at the Johns Hopkins Center for Health Security, said to the Post. However, while it is not expected to grow into a deadly pandemic, HMPV "should not be ignored," said virologist Connor Bamford in an opinion for The I Paper. "We must continue research into these viruses so we can better deploy interventions like vaccines, antivirals and preventative measures for known and unknown viruses in the future."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Devika Rao has worked as a staff writer at The Week since 2022, covering science, the environment, climate and business. She previously worked as a policy associate for a nonprofit organization advocating for environmental action from a business perspective.
-
With Dick Durbin’s retirement, where do Democrats go from here?
TODAY'S BIG QUESTION The number two Senate Democrat's pending departure is a pivotal moment for a party looking for leadership in the second Trump administration
By Rafi Schwartz, The Week US
-
6 peaceful homes in farm country
Feature Featuring a two-story solarium in California and a three-season screened porch in Wisconsin
By The Week US
-
5 'slow TV' shows for overstimulated kids
The Week Recommends In an era of fast-paced content and short attention spans, the slow TV movement can be a boon to parents
By Theara Coleman, The Week US
-
Strep infections are rising in the US
Under the radar The cases have more than doubled in 10 years
By Devika Rao, The Week US
-
Hantavirus: the rare pathogen linked to rodents that attacks the lungs
The Explainer Despite the low risk of contracting it, the virus could be potentially deadly
By Theara Coleman, The Week US
-
The sneaking rise of whooping cough
Under the Radar The measles outbreak isn't the only one to worry about
By Theara Coleman, The Week US
-
The tobacco industry could be the beneficiary of health agency cuts
The explainer Anti-tobacco initiatives may go up in smoke
By Devika Rao, The Week US
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths
By Peter Weber, The Week US
-
DVT: what to know about the blood clot plaguing NBA players
The Explainer Multiple players have been diagnosed with deep vein thrombosis over the past few months
By Theara Coleman, The Week US
-
What does Health and Human Services do?
The Explainer Cuts will 'dramatically alter' public health in America
By Joel Mathis, The Week US
-
Tuberculosis sees a resurgence and is only going to get worse
Under the radar The spread of the deadly infection is buoyed by global unrest
By Devika Rao, The Week US